Literature DB >> 7884671

Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs.

J C Scott-Moncrieff1, Z Shao, A K Mitra.   

Abstract

The pharmacokinetics and pharmacodynamics of porcine zinc insulin following intravenous (iv), intrajejunal, and ileocolonic delivery were evaluated in dogs. The concentration-time profile of plasma immunoreactive insulin following iv injection could be best described by a two-compartment model with a mean distribution half-life of 1.1 min and a mean elimination half-life of 5.6 min. Maximum hypoglycemia occurred at 15 min after injection. Intrajejunal administration of 10 units/kg insulin in phosphate-buffered saline resulted in minimal insulin absorption or hypoglycemia. Incorporation of mixed micelles containing 30 mM sodium glycocholate and 40 mM linoleic acid significantly improved enteral insulin absorption. When delivered with mixed micelles, the mean absolute bioavailability of insulin was 1.8%. To study the effect of intestinal site on insulin uptake, the same formulation was delivered to the ileocolonic region. The mean absolute bioavailability of insulin absorbed from this site was 0.6%. Delivery of insulin to both sites caused significant hypoglycemia in all dogs. Insulin combined with mixed micelles is enterally absorbed in dogs; however, the bioavailability is much lower than that observed in similar studies with rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7884671     DOI: 10.1002/jps.2600831020

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

Review 1.  Pharmacokinetic considerations of new insulin formulations and routes of administration.

Authors:  A Hoffman; E Ziv
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 2.  Oral controlled release technology for peptides: status and future prospects.

Authors:  J A Fix
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

3.  Ionic liquids for oral insulin delivery.

Authors:  Amrita Banerjee; Kelly Ibsen; Tyler Brown; Renwei Chen; Christian Agatemor; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

4.  A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine.

Authors:  S Lee; J Lee; D Y Lee; S K Kim; Y Lee; Y Byun
Journal:  Diabetologia       Date:  2005-03-01       Impact factor: 10.122

5.  Eudragit S100 entrapped insulin microspheres for oral delivery.

Authors:  Deepti Jain; Amulya K Panda; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

Review 6.  Theranostics Aspects of Various Nanoparticles in Veterinary Medicine.

Authors:  Ding-Ping Bai; Xin-Yu Lin; Yi-Fan Huang; Xi-Feng Zhang
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.